Trials / Completed
CompletedNCT02145364
Ultherapy® for the Treatment of Acne Scars
Evaluation of the Ulthera® System for Correction of Moderate to Severe Atrophic Acne Scars
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Ulthera, Inc · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, multi-site trial to be conducted at 2 clinical sites. Up to 20 subjects will receive study treatments. Following study treatments, follow-up visits will occur at 60, 90 and 180 days from each subject's last study treatment.
Detailed description
Subjects with moderate to severe atrophic acne scars will be enrolled. Subjects will receive up to three dual-depth treatments to the cheek and temple areas impacted by acne scars, treating the number of treatment squares necessary to cover the area of scarring. Each treatment square will receive 30 lines per transducer depth for a total of 60 lines per treatment square. Three treatments 30 days apart will be required.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ultherapy® treatment | Microfocused ultrasound treatment |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-07-01
- Completion
- 2015-10-01
- First posted
- 2014-05-22
- Last updated
- 2017-12-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02145364. Inclusion in this directory is not an endorsement.